Iran's Astan Quds Razavi, Defense Ministry to launch production line of Fakhra vaccine
Iran's Astan Quds Razavi (AQR) and Defense Ministry will launch over the next 10 days a production line for a domestically-developed COVID-19 vaccine developed by a research center formerly headed by nuclear scientist Mohsen Fakhrizadeh, who was assassinated last year.
Malek Rahmati, the AQR’s deputy chief custodian, made the announcement on Thursday, saying the production line for the Iranian vaccine, Fakhra, will open on June 22, coinciding with the birthday anniversary of Imam Reza (AS) — Muslims' eighth Imam.
Astan Quds Razavi (AQR) is an organization based in the Iranian city of Mashhad that manages the holy shrine of Imam Reza (AS).
Rahmati said the commercial and industrial development phase of Fakhra will start with the help of Astan Quds Razavi and under the supervision of the Health Ministry at the Samen Pharmaceutical Company in the holy city of Mashhad.
Iran launched the second phase in the human trial of Fakhra on Wednesday, with officials in charge of the vaccine’s clinical trial saying 135 volunteers got jabs in the first phase and that the vaccine proved to be “safe and secure.”
In addition to Fakhra, Iran has developed three other vaccines against the COVID-19 disease named COVIran Barekat, Razi COV-Pars and the joint Iran-Cuba vaccine.
It has also imported foreign vaccines despite the illegal US sanctions that have seriously hampered the country’s fight against the coronavirus pandemic.